Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.2114 +0.0214 (+11.26%)
Streaming Delayed Price Updated: 3:48 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pressure Biosciences

< Previous 1 2 3 4 5 6 7 Next >
Pressure BioSciences Receives Record Nearly $600,000 Order for 16 PCT Instruments
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), One World Products Inc. (OWPC) Team up to Deliver Sports Performance/Recovery Drinks
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences and One World Products Announce Partnership in Development of CBD-Nanoemulsion Sports Performance/Recovery Drinks
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Results of Consumer Focus Group Testing THC Nanoemulsion Oral Spray
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences, Inc. to Discuss Third Quarter 2022 Financial Results and Provide Business Update
Via ACCESSWIRE
Pressure BioSciences Nanoemulsions Platform Forging Game-Changing Future for Cannabis Industry
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q4 2022 Guidance, Projections for 2023
Via Investor Brand Network
Pressure BioSciences Gives Guidance for Strong Q4 2022 Sales Followed by Rapid Revenue Growth from Multiple Large Industries in 2023
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Confirms Shipment of Revolutionary Nanoemulsion Product
Via Investor Brand Network
Pressure BioSciences Announces First Commercial Production of Revolutionary UltraShear Nanoemulsion Product Shipped, Booked, and Paid
Via ACCESSWIRE
Next Generation Skincare Products Company Signs Partnership with QVC Skincare Leader Dr. Denese SkinScience: Pressure BioSciences, Inc. (Stock Symbol: PBIO)
Via Get News
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Potential Q2 2023 Commercial Sales of Dr. Denese SkinScience, UltraShear Nanoemulsion-Enabled Products
Via Investor Brand Network
Pressure BioSciences Partnership with QVC Skincare Leader Dr. Denese SkinScience Yields Unprecedented Effectiveness in Skin Tightening and Wrinkle Reduction
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured on Stock Day Podcast
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Securing and Fulfilling UltraShear Nanoemulsions Contracts, Discussed on "Stock Day Podcast"
Phoenix, Arizona--(Newsfile Corp. - December 5, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences, Inc. Reports Q3 2022 Financial Results and Offers Business Update on Ultra Shear Technology Nanoemulsions Commercialization Progress
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2022 Results, Provide Business Update
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Dr. Denese SkinScience to Introduce UST Nanoemulsion Hair Regrowth Product in 2023
Via Investor Brand Network
Pressure BioSciences and Leading Cosmeceuticals Innovator Dr. Denese SkinScience to Introduce Revolutionary UST Nanoemulsion Hair Regrowth Product in 2023
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Emerging Growth Conference Presentation
Via Investor Brand Network
Pressure BioSciences and Leading Cosmeceuticals Company Dr. Denese SkinScience Present Their Partnership Progress in FORCE Family Office October 13th Webinar
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Focus on Launch of Proprietary UST Processing Method in Emerging Growth Conference Presentation
Via Investor Brand Network
Imminent Commercial Launch of Revolutionary UST Processing Method to be Focus of Pressure BioSciences Presentation at Emerging Growth Conference 40 on September 28, 2022
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Academia-Industry Partnership with The Ohio State University
Via Investor Brand Network
Unique Advantages and Commercial Process Scalability of Pressure BioSciences Revolutionary UST Platform Illuminated at the Conference of Food Engineering 2022
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation at H. C. Wainwright Annual Global Investment Conference
Via Investor Brand Network
Pressure BioSciences to Expand on Pivotal Change in Business Strategy with Presentation at H. C. Wainwright Annual Global Investment Conference on September 13th
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Partners with Skincare Leader, Icon and Pioneer
Via Investor Brand Network
Global Cosmeceuticals Market Size Projected Reach $96 Billion By 2029 as Demand is Booming
Palm Beach, FL – August 24, 2022 – FinancialNewsMedia.com News Commentary – The demand for cosmeceutical products is growing globally due to the rising prevalence of skin and hair disorders, increasing... 
Via FinancialNewsMedia
Exposures COVID-19
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform with Dr. Denese SkinScience, 20-Year Leader with Over $0.5 Billion in QVC Sales
Collaborative UST-Driven Research and Development Agreement Announced with Dr. Adrienne Denese (QVC Icon, Skincare Visionary, Anti-Aging Pioneer, & Creator of Award-Winning SkinScience Labs) Targets... 
Via FinancialNewsMedia
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.